Article
MicroRNAs as novel biomarkers for rivaroxaban therapeutic drug monitoring
13 Aug 2021
Abstract excerpt
Abstract Objectives The aim of this study is to assess micro-RNAs miR-142 and miR-39 as potential biomarkers for drug-monitoring of rivaroxaban among elderly patients with atrial fibrillation. Methods The study involved 57 patients with median (ME) age 87 years [80–94 years old] with nonvalvular atrial fibrillation admitted to a multidisciplinary hospital in Moscow. High-performance liquid chromatography with...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
